PAP

Persistent Asset Partners Portfolio holdings

AUM $114M
This Quarter Return
+2.01%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$113M
AUM Growth
+$113M
Cap. Flow
+$3.12M
Cap. Flow %
2.76%
Top 10 Hldgs %
41.39%
Holding
181
New
48
Increased
25
Reduced
30
Closed
34

Sector Composition

1 Healthcare 63.66%
2 Financials 21.94%
3 Materials 3.92%
4 Energy 1.87%
5 Industrials 0.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
OLMA icon
101
Olema Pharmaceuticals
OLMA
$420M
$86.4K 0.07%
+22,988
New +$86.4K
AVR
102
Anteris Technologies Global Corp. Common Stock
AVR
$143M
$84.9K 0.07%
+23,317
New +$84.9K
GOSS icon
103
Gossamer Bio
GOSS
$582M
$68.2K 0.06%
61,984
-3,910
-6% -$4.3K
PRQR icon
104
ProQR Therapeutics
PRQR
$235M
$63.6K 0.05%
+47,783
New +$63.6K
ELDN icon
105
Eledon Pharmaceuticals
ELDN
$154M
$50.4K 0.04%
14,855
TERN icon
106
Terns Pharmaceuticals
TERN
$653M
$35.3K 0.03%
12,807
SGMT icon
107
Sagimet Biosciences
SGMT
$235M
$34.5K 0.03%
+10,597
New +$34.5K
CADL icon
108
Candel Therapeutics
CADL
$318M
$33.4K 0.03%
5,918
-128
-2% -$723
MODV
109
DELISTED
ModivCare
MODV
$11.5K 0.01%
8,757
VNDA icon
110
Vanda Pharmaceuticals
VNDA
$281M
$7.13K 0.01%
+1,553
New +$7.13K
AFRM icon
111
Affirm
AFRM
$27.4B
0
AGIO icon
112
Agios Pharmaceuticals
AGIO
$2.22B
0
ALT icon
113
Altimmune
ALT
$320M
0
ALXO icon
114
ALX Oncology
ALXO
$55.2M
0
AMGN icon
115
Amgen
AMGN
$153B
0
ANAB icon
116
AnaptysBio
ANAB
$577M
0
ARQT icon
117
Arcutis Biotherapeutics
ARQT
$1.85B
-22,810
Closed -$302K
JBIO
118
Jade Biosciences, Inc. Common Stock
JBIO
$253M
0
BBIO icon
119
BridgeBio Pharma
BBIO
$9.91B
0
BMEA icon
120
Biomea Fusion
BMEA
$119M
0
BPMC
121
DELISTED
Blueprint Medicines
BPMC
-9,693
Closed -$1.09M
CAPR icon
122
Capricor Therapeutics
CAPR
$287M
0
CASH icon
123
Pathward Financial
CASH
$1.81B
-10,558
Closed -$842K
CLDX icon
124
Celldex Therapeutics
CLDX
$1.5B
0
CMPX icon
125
Compass Therapeutics
CMPX
$476M
0